Filing Details
- Accession Number:
- 0001209191-14-073398
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-05 16:25:57
- Reporting Period:
- 2014-12-04
- Filing Date:
- 2014-12-05
- Accepted Time:
- 2014-12-05 16:25:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1453943 | Thomas Connolly | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-12-04 | 937 | $53.74 | 35,832 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-12-04 | 500 | $118.40 | 35,332 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-04 | 337 | $119.36 | 34,995 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-04 | 100 | $120.62 | 34,895 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-12-04 | 937 | $0.00 | 937 | $53.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,563 | 2022-09-03 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 150 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $118.40 (range $117.92 to $118.86).
- Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $119.36 (range $118.95 to $119.82).
- The option vests in 16 quarterly installments from 09/04/2012.
Billionaire Hedge Funds
